All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

14

Reset

14 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • hUC-MSCsmesenchymal stem cells, MSCPhase 38 trials

    Shenzhen Wingor Biotechnology Co., Ltd. · Knee Osteoarthritis, Crohn&Amp;#39;s, Crohn&Amp;#39;s Disease (CD)

  • ObicetrapibPhase 37 trials

    NewAmsterdam Pharma · Lipidemia, Preclinical Alzheimer's Disease, Antioxidant Absorption

  • ZiltivekimabPhase 34 trials

    Novo Nordisk · Acute Myocardial Infarction (AMI), Myocardial Infarction, Heart Failure

  • ezetimibe FDCPhase 32 trials

    NewAmsterdam Pharma · Lipidemia, Coronary Artery Disease, Plaque, Atherosclerotic

  • EA-230hourPhase 31 trial

    EBI Anti Sepsis BV · Coronary Artery Disease (CAD), Coronary Artery Bypass Graft Surgery(CABG)

  • XTR00499mTechnicium Sestamibi, Procedure: Coronary angiographyPhase 31 trial

    Sinotau Pharmaceutical Group · Coronary Artery Disease(CAD)

  • SRSD107Phase 22 trials

    Sirius Therapeutics Co., Ltd. · Venous Thromboembolism, Coronary Artery Disease (CAD), Peripheral Arterial Disease

  • YN001Phase 22 trials

    Beijing Inno Medicine Co., Ltd. · Atherosclerosis, Coronary Artery Disease, Atherosclerotic Cardiovascular Disease

  • A195Phase 21 trial

    XyloCor Therapeutics, Inc. · Coronary Artery Disease (CAD)

  • HeXell-2020Phase 21 trial

    Hexun Biosciences Co., LTD. · Coronary Artery Disease

  • RBD1119Phase 21 trial

    Ribocure Pharmaceuticals AB · Stable Coronary Artery Disease

  • RBD4059Phase 21 trial

    Ribocure Pharmaceuticals AB · Stable Coronary Artery Disease CAD

  • XC001Phase 21 trial

    XyloCor Therapeutics, Inc. · Coronary Artery Disease (CAD)

  • YMI024Phase 21 trial

    Novartis · Coronary Artery Disease

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.